RSV vaccine added to NIP for over 75s

Government moves to eliminate cost barrier to accessing the RSV vaccine for older Australians  The federal government is investing $445.3 million to deliver free respiratory syncytial virus (RSV) vaccines to eligible patients from 15 May 2026, through the National Immunisation Program (NIP).  Funded doses of the vaccine will be available to Australians aged 75 years and older, and